Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
New England Journal of Medicine 2023 03 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial Rosenstock J, Frias J, Jastreboff AM, et al
In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Retatrutides effects go far beyond obesity
It is mainly used as an intermediate in the production of other chemicals
US$ 28.82
US$ 29.31
US$ 29.00
US$ 20.84
US$ 21.79
US$ 25.58
US$ 20.10
US$ 23.98
US$ 27.27
US$ 22.42
